Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the authors describe the spectrum of integrated PET/CT findings on neuroendocrine (NE) tumors of the lung. We also demonstrate the usefulness of this imaging modality in patients with known or suspected NE tumors of the lung.

Author

Semin Chong and Kyung Soo Lee

Contact Details

Corresponding address:
Kyung Soo Lee, MD, Department of Radiology, Samsung Medical Center,
Sungkyunkwan University School of Medicine, 50, Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea

Reference

ICIS Cancer Imaging Volume 7 Issue 1
DOI: 10.1102/1470-7330.2007.0028

Date Posted

26 November 2007

Print PDF

Size

5.03 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	20 seconds
ADSL 512Kb/s (Broadband):	1 minute 20 seconds
64 Kb/s (ISDN):	10 minutes 44 seconds
33.3 Kb/s (Typical Modem):	20 minutes 37 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 231 7773 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.